Thioredoxin prevents the development and progression of elastase-induced emphysema

Biochemical and Biophysical Research Communications

Volumn 354, Issue 3, 2007, Pages 712-719

  Kinoshita, Takashi ^a   Hoshino, Tomoaki ^a   Imaoka, Haruki ^a   Ichiki, Hiroko ^a   Okamoto, Masaki ^a   Kawayama, Tomotaka ^a   Yodoi, Junji ^b   Kato, Seiya ^c   Aizawa, Hisamichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

COPD; Emphysema; Oxidant stress; Redox; Thioredoxin

Indexed keywords

ELASTASE; RECOMBINANT PROTEIN; RECOMBINANT THIOREDOXIN 1; THIOREDOXIN; UNCLASSIFIED DRUG;

AEROSOL; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; LUNG EMPHYSEMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; DISEASE PROGRESSION; EMPHYSEMA; MICE; MICE, TRANSGENIC; OXIDATION-REDUCTION; PANCREATIC ELASTASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; THIOREDOXIN; TIME FACTORS;

MUS;

EID: 33846617810     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.01.053     Document Type: Article

References (24)

1. Tagaya Y., Maeda Y., Mitsui A., Kondo N., Matsui H., Hamuro J., Brown N., Arai K., Yokota T., Wakasugi H., et al. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 8 (1989) 757-764
2. Holmgren A., and Bjornstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol. 252 (1995) 199-208
3. Nakamura H., Nakamura K., and Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 15 (1997) 351-369
4. Okamoto M., Kato S., Oizumi K., Kinoshita M., Inoue Y., Hoshino K., Akira S., McKenzie A.N., Young H.A., and Hoshino T. Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia. Blood 99 (2002) 1289-1298
5. Hoshino T., Nakamura H., Okamoto M., Kato S., Araya S., Nomiyama K., Oizumi K., Young H.A., Aizawa H., and Yodoi J. Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury. Am. J. Respir. Crit. Care Med. 168 (2003) 1075-1083
6. Ichiki H., Hoshino T., Kinoshita T., Imaoka H., Kato S., Inoue H., Nakamura H., Yodoi J., Young H.A., and Aizawa H. Thioredoxin suppresses airway hyperresponsiveness and airway inflammation in asthma. Biochem. Biophys. Res. Commun. 334 (2005) 1141-1148
7. Massaro G.D., and Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat. Med. 3 (1997) 675-677
8. Hoshino T., Kawase Y., Okamoto M., Yokota K., Yoshino K., Yamamura K., Miyazaki J., Young H.A., and Oizumi K. Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. J. Immunol. 166 (2001) 7014-7018
9. Saetta M., Shiner R.J., Angus G.E., Kim W.D., Wang N.S., King M., Ghezzo H., and Cosio M.G. Destructive index: a measurement of lung parenchymal destruction in smokers. Am. Rev. Respir. Dis. 131 (1985) 764-769
10. Wang Z., Zheng T., Zhu Z., Homer R.J., Riese R.J., Chapman Jr. H.A., Shapiro S.D., and Elias J.A. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J. Exp. Med. 192 (2000) 1587-1600
11. Kobayashi M., Tanaka A., Hayashi Y., and Shimamura S. The CMV enhancer stimulates expression of foreign genes from the human EF-1 alpha promoter. Anal. Biochem. 247 (1997) 179-181
12. Gill D.R., Smyth S.E., Goddard C.A., Pringle I.A., Higgins C.F., Colledge W.H., and Hyde S.C. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther. 8 (2001) 1539-1546
13. Christensen T.G., Korthy A.L., Snider G.L., and Hayes J.A. Irreversible bronchial goblet cell metaplasia in hamsters with elastase-induced panacinar emphysema. J. Clin. Invest. 59 (1977) 397-404
14. Shapiro S.D. Animal models for COPD. Chest 117 (2000) 223S-227S
15. Aoshiba K., Yokohori N., and Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am. J. Respir. Cell Mol. Biol. 28 (2003) 555-562
16. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 163 (2001) 1256-1276
17. MacNee W. Oxidants/antioxidants and COPD. Chest 117 (2000) 303S-317S
18. Foronjy R.F., Mirochnitchenko O., Propokenko O., Lemaitre V., Jia Y., Inouye M., Okada Y., and D'Armiento J.M. Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice. Am. J. Respir. Crit. Care Med. 173 (2006) 623-631
19. Aoshiba K., Yasuda K., Yasui S., Tamaoki J., and Nagai A. Serine proteases increase oxidative stress in lung cells. Am. J. Physiol. Lung Cell Mol. Physiol. 281 (2001) L556-L564
20. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3 (2003) 745-756
21. Nakamura T., Nakamura H., Hoshino T., Ueda S., Wada H., and Yodoi J. Redox regulation of lung inflammation by thioredoxin. Antioxid. Redox. Signal. 7 (2005) 60-71
22. Burge P.S., Calverley P.M., Jones P.W., Spencer S., Anderson J.A., and Maslen T.K. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 320 (2000) 1297-1303
23. Man S.F., and Sin D.D. Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2 (2005) 78-82
24. Mao J.T., Goldin J.G., Dermand J., Ibrahim G., Brown M.S., Emerick A., McNitt-Gray M.F., Gjertson D.W., Estrada F., Tashkin D.P., and Roth M.D. A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am. J. Respir. Crit. Care Med. 165 (2002) 718-723